Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats

Journal of Hypertension

Volumn 27, Issue SUPPL. 6, 2009, Pages

  Zeman, Michal ^a   Szántóová, Kristina ^a   Stebelová, Katarina ^a   Mravec, Boris ^a,b   Herichová, Iveta ^a  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Angiotensin; Bmal1; Body weight; Circadian; Hypertrophy; Per2; Renin

Indexed keywords

DRINKING WATER; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN RECEPTOR; PER2 PROTEIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; HEART; HYPERTENSION; LIGHT DARK CYCLE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSCILLATOR; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SUPRACHIASMATIC NUCLEUS;

EID: 68249127910     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000358833.41181.f6     Document Type: Article

References (29)

1. Scheer FA, Ter Horst GJ, van Der Vliet J, Buijs RM. Physiological and anatomic evidence for regulation of the heart by suprachiasmatic nucleus in rats. Am J Physiol Heart Circ Physiol 2001 ; 280:1391-1399.
2. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 2001; 88:1142-1150. (Pubitemid 34132514)
3. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000; 289:2344-2347. (Pubitemid 30739737)
4. McNamara P, Seo SP, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 2001; 105:877-889. (Pubitemid 32635089)
5. Herichova I, Mravec B, Stebelová K, Križanová O, Jurkovičová D, Kvetňnanský R, et al. Rhythmic clock gene expression in heart, kidney and some brain nuclei involved in blood pressure control in hypertensive TGR(mREN-2)27 rats. Mol Cell Biochem 2007; 296:25-34. (Pubitemid 350018738)
6. Challet E. Minireview: Entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 2007; 148:5648-5655. (Pubitemid 350146137)
7. Schuhler S, Pitrosky B, Kirsch R, Pévet P. Entrainment of locomotor activity rhythm in pinealectomized adult Syrian hamsters by daily melatonin infusion. Behav. Brain Res 2002; 133:343-350. (Pubitemid 34754409)
8. Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007; 42:319-322.
9. Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003; 12:19-24. (Pubitemid 36416949)
10. Zeman M, Dulková K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci 2005; 76:1795-1803. (Pubitemid 40215221)
11. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344:541-544. (Pubitemid 20124430)
12. Lemmer B, Mattes A, Böhm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22:97-101. (Pubitemid 23187390)
13. Lemmer B, Witte K, Enzminger H, Schiffer S, Hauptfleisch S. Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of the brain, the heart, and the kidneys. Chronobiol Int 2003; 20:711-738. (Pubitemid 36927466)
14. Zeman M, Petrak J, Stebelová K, Nagy G, Križanová O, Herichova I, et al. Endocrine rhythms and expression of selected genes in the brain, stellate ganglia and adrenals of hypertensive TGR rats. Ann NY Acad Sci 2008; 1148:308-316.
15. Enzminger H, Witte K, Lemmer B. Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin Il in cultured pinealocytes. J Pineal Res 2001; 31:256-263. (Pubitemid 32905236)
16. Monošiková J, Herichová I, Mravec B, Kiss A, Zeman M. Effect of upregulated renin-angiotensin system on per2 and bmall gene expression in brain structures involved in blood pressure control in TGR(mREN-2)27 rats. Brain Res 2007; 1180:29-38. (Pubitemid 350018738)
17. Zeman M, Nosál'ová V, Bobek P, Zákalová M. Changes of endogenous melatonin and protective effect of diet containing pleuran and extract of black elder in colonic inflammation in rats. Biologia 2001; 6:691-697.
18. Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140:1009-1012.
19. Bojková B, Orendás P, Friedmanová L, Kassayová M, Dateiinka I, Ahlersová E, et al Prolonged melatonin administration in 6-month-old SpragueDawley rats: metabolic alterations. Acta Physiol Hung 2008; 95:65-76.
20. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141:487-497. (Pubitemid 32250470)
21. Kršková L, Vrabcová M, Zeman M. Effect of melatonin on exploration and anxiety in normotensive and hypertensive rats with high activity of reninangiotensin system. Neuro Endocrinol Lett 2007; 28:295-301. (Pubitemid 47045774)
22. Wilson W, Voigt P, Bader M, Marsden CA, Fink H. Behaviour of the transgenic (mREN2)27 rat. Brain Res 1996; 729:1-9.
23. Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology (Berl) 1990; 100:222-226. (Pubitemid 20038566)
24. Poirel VJ, Boggio V, Dardente H, Pevet P, Masson-Pevet M, Gauer F. Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei. Neuroscience 2003; 120:745-755. (Pubitemid 36928071)
25. Pecháňová O, Zicha J, Paulis L, Zenebe W, Dobesová Z, Kojsová S, et al. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007; 561:129-136. (Pubitemid 46435853)
26. K-Laflamme A, Wu L, Foucart S, de Champlain J. Impaired basal sympathetic tone and alphal -adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11:219-229. (Pubitemid 28137615)
27. Rechcinski T, Kurpesa M, Trzos E, Krzeminska-Pakula M. The influence of melatonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease - preliminary report. Pol Arch Med Wewn 2006; 115:520-528. (Pubitemid 44784420)
28. Witte K, Grebmer W, Sealbert E, Delagrange P, Guardiola-Lemaître B, Lemmer B. Effects of melatoninergic agonists on light-suppressed circadian rhythms in rats. Physiol Behav 1998; 65:219-224. (Pubitemid 28548641)
29. Young ME, Razeghi P, Cedars AM, Guthrie PH, Taegtmeyer H. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 2001; 89:1199-1208. (Pubitemid 34627879)